Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Therapeutic Advances in Hematology
|
November 6, 2023
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis
Francesco Mannelli, Francesca Crupi, Roberta Zanotti, et al.
Cancers
|
September 24, 2020
Small Molecule Inhibitors of Microenvironmental Wnt/β-Catenin Signaling Enhance the Chemosensitivity of Acute Myeloid Leukemia
Paul Takam Kamga, Giada Dal Collo, Adriana Cassaro, et al.
Critical Reviews in Oncology/Hematology
|
June 4, 2021
Efficacy of R-COMP in comparison to R-CHOP in patients with DLBCL: A systematic review and single-arm metanalysis
Carlo Visco, Francesca Pregnolato, Isacco Ferrarini, et al.
Cancers
|
December 11, 2019
Notch Signaling Molecules as Prognostic Biomarkers for Acute Myeloid Leukemia
Paul Takam Kamga, Giada Dal Collo, Federica Resci, et al.
Allergy
|
October 21, 2025
Safety of Drug Provocation Tests in Adults With and Without Clonal Mast Cell Disorders
Francesca Nalin, Bianca Olivieri, Francesco Olivieri, et al.
Bone
|
June 1, 2024
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal
Ilaria Tanasi, Lara Crosera, Francesco Taus, et al.
Annals of Hematology
|
August 22, 2025
PNH clones prevalence study in ph-negative myeloproliferative neoplasms: a multicenter Italian study
Alessandra D'Addio, Michela Rondoni, Marzia Salvucci, et al.
Leukemia Research
|
February 12, 2022
Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience
Eleonora De Bellis, Silvia Imbergamo, Anna Candoni, et al.
Annals of Hematology
|
March 24, 2023
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study
Davide Lazzarotto, Ilaria Tanasi, Antonella Vitale, et al.
Journal of Clinical Medicine
|
February 13, 2025
New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers
Giulia Battaglia, Davide Lazzarotto, Ilaria Tanasi, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Therapeutic Advances in Hematology
|
November 6, 2023
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis
Francesco Mannelli, Francesca Crupi, Roberta Zanotti, et al.
Cancers
|
September 24, 2020
Small Molecule Inhibitors of Microenvironmental Wnt/β-Catenin Signaling Enhance the Chemosensitivity of Acute Myeloid Leukemia
Paul Takam Kamga, Giada Dal Collo, Adriana Cassaro, et al.
Critical Reviews in Oncology/Hematology
|
June 4, 2021
Efficacy of R-COMP in comparison to R-CHOP in patients with DLBCL: A systematic review and single-arm metanalysis
Carlo Visco, Francesca Pregnolato, Isacco Ferrarini, et al.
Cancers
|
December 11, 2019
Notch Signaling Molecules as Prognostic Biomarkers for Acute Myeloid Leukemia
Paul Takam Kamga, Giada Dal Collo, Federica Resci, et al.
Allergy
|
October 21, 2025
Safety of Drug Provocation Tests in Adults With and Without Clonal Mast Cell Disorders
Francesca Nalin, Bianca Olivieri, Francesco Olivieri, et al.
Bone
|
June 1, 2024
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal
Ilaria Tanasi, Lara Crosera, Francesco Taus, et al.
Annals of Hematology
|
August 22, 2025
PNH clones prevalence study in ph-negative myeloproliferative neoplasms: a multicenter Italian study
Alessandra D'Addio, Michela Rondoni, Marzia Salvucci, et al.
Leukemia Research
|
February 12, 2022
Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience
Eleonora De Bellis, Silvia Imbergamo, Anna Candoni, et al.
Annals of Hematology
|
March 24, 2023
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study
Davide Lazzarotto, Ilaria Tanasi, Antonella Vitale, et al.
Journal of Clinical Medicine
|
February 13, 2025
New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers
Giulia Battaglia, Davide Lazzarotto, Ilaria Tanasi, et al.
Page
of 3